INGR
Neutral signalScored 2026-08-07 Drivers: Congress, fundamentals. Moteurs : Congrès, fondamentaux.
Research, not advice.
À propos
Ingredion Incorporated
- Nom
- Ingredion Incorporated
- Secteur
- Consumer Defensive
- Industrie
- Packaged Foods
- Bourse
- NYSE
- Capitalisation
- $6.0B
- Employés
- 11,200
- PDG
- James Zallie
- Site web
- https://www.ingredion.com
- Marché
- CAGCPBDARLWOLLIPOST
Ingredion Incorporated, along with its affiliated entities, specializes in the global production and sale of starches and sweeteners, catering to a diverse range of industries. The company's operations are strategically organized into four geographical segments: North America, South America, Asia-Pacific, and Europe, the Middle East, and Africa. Its extensive product portfolio includes a variety of sweetener solutions such as glucose, high maltose, and high fructose corn syrups, as well as caramel colors, dextrose, polyols, maltodextrins, and glucose syrup solids. Beyond sweeteners, Ingredion also provides food-grade and industrial starches, biomaterials, and key nutrition ingredients. The company further offers specific corn-derived products like edible corn oil, and refined corn oil supplied to manufacturers of cooking oils, margarine, salad dressings, shortening, and mayonnaise. It also produces corn gluten feed, a protein source for poultry, pet food, and aquaculture. Additionally, Ingredion processes fruit and vegetable products, delivering concentrates, purees, essences, pulse proteins, and hydrocolloid systems and blends. These ingredients are predominantly extracted from corn, alongside other starch-rich raw materials such as tapioca, potatoes, and rice. Ingredion's primary clientele hails from the food, beverage, brewing, and animal nutrition sectors. Established in 1906, the firm was initially known as Corn Products International, Inc., before officially rebranding to Ingredion Incorporated in June 2012. Its corporate headquarters are situated in Westchester, Illinois.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 1 662 titres (~170 039,22 $ US)
- Insiders
- Fischer David B
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$170,039
Avg sell (VWAP, 90d window) $102.31 vs last close —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-08-05
- Last synced
-
2026-08-11 09:46:50
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-08-05 | Fischer David B | Sell · S | 1,662 | $102.31 | $170,039 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2025-09-25 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2025-07-10 | Lisa McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-06-24 | Lisa McClain | Purchase | $1,001 - $15,000 |
Signal
Neutral signalScored 2026-08-07 Drivers: Congress, fundamentals. Moteurs : Congrès, fondamentaux.
INGR combines robust financial health (liquidity: 90, fundamentals: 85) with a confirmed Q2 2026 earnings beat and 7% volume growth in its high-value Texture & Healthful Solutions segment, supported by institutional…
The first sentence of the analysis written for INGR on 2026-08-07 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Supports a bullish reading. 2 purchase disclosures year to date
- Narrative Supports a bullish reading. Stored narrative reading is in the bullish band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Supports a bullish reading. Current ratio 2.66 · operating margin 14%
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 25.3% | 24.1% | 21.4% | 18.8% | 19.3% | |
| Ebit Margin | 14.0% | 13.1% | 11.7% | 9.7% | 4.7% | |
| Ebitda Margin | 17.1% | 15.9% | 14.4% | 12.4% | 7.9% | |
| Operating Profit Margin | 14.4% | 11.9% | 11.7% | 9.6% | 4.5% | |
| Pretax Profit Margin | 13.5% | 12.5% | 10.3% | 8.4% | 3.6% | |
| Continuous Operations Profit Margin | 10.2% | 8.8% | 8.0% | 6.3% | 1.8% | |
| Net Profit Margin | 10.1% | 8.7% | 7.9% | 6.2% | 1.7% | |
| Bottom Line Profit Margin | 10.1% | 8.7% | 7.9% | 6.2% | 1.7% | |
| Current Ratio | 2.663 | 2.619 | 1.918 | 1.758 | 1.784 | |
| Quick Ratio | 1.731 | 1.692 | 1.100 | 0.910 | 1.009 | |
| Solvency Ratio | 0.269 | 0.242 | 0.216 | 0.164 | 0.089 | |
| Cash Ratio | 0.783 | 0.778 | 0.226 | 0.125 | 0.217 | |
| Price To Earnings Ratio | 9.706 | 13.923 | 11.143 | 13.180 | 55.540 | |
| Price To Earnings Growth Ratio | 0.648 | 9.686 | 0.358 | 0.040 | -0.836 | |
| Forward Price To Earnings Growth Ratio | 0.648 | 9.686 | 0.358 | 0.040 | -0.836 | |
| Price To Earnings Diluted Ratio | 9.862 | 14.167 | 11.305 | 13.342 | 55.861 | |
| Price To Earnings Diluted Growth Ratio | 0.651 | 12.364 | 0.367 | 0.041 | -0.841 | |
| Price To Book Ratio | 1.632 | 2.332 | 1.994 | 2.029 | 2.068 | |
| Price To Sales Ratio | 0.981 | 1.213 | 0.878 | 0.816 | 0.941 | |
| Price To Free Cash Flow Ratio | 13.853 | 7.938 | 9.667 | -43.804 | 70.484 | |
| Price To Operating Cash Flow Ratio | 7.499 | 6.274 | 6.777 | 42.651 | 16.542 | |
| Debt To Assets Ratio | 0.227 | 0.273 | 0.314 | 0.354 | 0.321 | |
| Debt To Equity Ratio | 0.413 | 0.527 | 0.668 | 0.838 | 0.717 | |
| Debt To Capital Ratio | 0.292 | 0.345 | 0.401 | 0.456 | 0.417 | |
| Long Term Debt To Capital Ratio | 0.287 | 0.316 | 0.326 | 0.378 | 0.357 | |
| Financial Leverage Ratio | 1.820 | 1.927 | 2.127 | 2.367 | 2.232 | |
| Working Capital Turnover Ratio | 3.387 | 4.015 | 5.344 | 6.084 | 5.808 | |
| Operating Cash Flow Ratio | 0.717 | 1.121 | 0.597 | 0.081 | 0.259 | |
| Operating Cash Flow Sales Ratio | 0.131 | 0.193 | 0.130 | 0.019 | 0.057 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.541 | 0.790 | 0.701 | -0.974 | 0.235 | |
| Debt Service Coverage Ratio | 11.706 | 10.928 | 1.751 | 1.271 | 1.097 | |
| Interest Coverage Ratio | 28.027 | 22.641 | 8.395 | 7.697 | 4.189 | |
| Short Term Operating Cash Flow Coverage Ratio | 19.667 | 32.636 | 2.359 | 0.280 | 1.273 | |
| Operating Cash Flow Coverage Ratio | 0.527 | 0.706 | 0.440 | 0.057 | 0.174 | |
| Capital Expenditure Coverage Ratio | 2.180 | 4.771 | 3.345 | 0.507 | 1.307 | |
| Dividend Paid And Capex Coverage Ratio | 1.466 | 2.810 | 2.073 | 0.316 | 0.810 | |
| Dividend Payout Ratio | 0.289 | 0.325 | 0.302 | 0.368 | 1.573 | |
| Enterprise Value Multiple | 6.357 | 8.487 | 7.818 | 9.088 | 15.505 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 25.3% | ▲1.2% | ▲3.5% |
| Ebit Margin | 14.0% | ▲0.9% | ▲3.4% |
| Ebitda Margin | 17.1% | ▲1.1% | ▲3.6% |
| Operating Profit Margin | 14.4% | ▲2.5% | ▲4.0% |
| Pretax Profit Margin | 13.5% | ▲1.0% | ▲3.8% |
| Continuous Operations Profit Margin | 10.2% | ▲1.4% | ▲3.2% |
| Net Profit Margin | 10.1% | ▲1.4% | ▲3.2% |
| Bottom Line Profit Margin | 10.1% | ▲1.4% | ▲3.2% |
| Current Ratio | 2.663 | ▲0.044 | ▲0.515 |
| Quick Ratio | 1.731 | ▲0.039 | ▲0.443 |
| Solvency Ratio | 0.269 | ▲0.027 | ▲0.073 |
| Cash Ratio | 0.783 | ▲0.004 | ▲0.357 |
| Price To Earnings Ratio | 9.706 | ▼-4.217 | ▼-10.992 |
| Price To Earnings Growth Ratio | 0.648 | ▼-9.039 | ▼-1.331 |
| Forward Price To Earnings Growth Ratio | 0.648 | ▼-9.039 | ▼-1.331 |
| Price To Earnings Diluted Ratio | 9.862 | ▼-4.305 | ▼-11.045 |
| Price To Earnings Diluted Growth Ratio | 0.651 | ▼-11.712 | ▼-1.865 |
| Price To Book Ratio | 1.632 | ▼-0.700 | ▼-0.379 |
| Price To Sales Ratio | 0.981 | ▼-0.232 | ▲0.015 |
| Price To Free Cash Flow Ratio | 13.853 | ▲5.914 | ▲2.225 |
| Price To Operating Cash Flow Ratio | 7.499 | ▲1.224 | ▼-8.450 |
| Debt To Assets Ratio | 0.227 | ▼-0.047 | ▼-0.071 |
| Debt To Equity Ratio | 0.413 | ▼-0.114 | ▼-0.220 |
| Debt To Capital Ratio | 0.292 | ▼-0.053 | ▼-0.090 |
| Long Term Debt To Capital Ratio | 0.286 | ▼-0.030 | ▼-0.046 |
| Financial Leverage Ratio | 1.820 | ▼-0.106 | ▼-0.274 |
| Working Capital Turnover Ratio | 3.387 | ▼-0.628 | ▼-1.541 |
| Operating Cash Flow Ratio | 0.717 | ▼-0.404 | ▲0.162 |
| Operating Cash Flow Sales Ratio | 0.131 | ▼-0.062 | ▲0.025 |
| Free Cash Flow Operating Cash Flow Ratio | 0.541 | ▼-0.249 | ▲0.283 |
| Debt Service Coverage Ratio | 11.706 | ▲0.778 | ▲6.355 |
| Interest Coverage Ratio | 28.027 | ▲5.386 | ▲13.837 |
| Short Term Operating Cash Flow Coverage Ratio | 19.667 | ▼-12.970 | ▲8.424 |
| Operating Cash Flow Coverage Ratio | 0.527 | ▼-0.178 | ▲0.146 |
| Capital Expenditure Coverage Ratio | 2.180 | ▼-2.591 | ▼-0.242 |
| Dividend Paid And Capex Coverage Ratio | 1.466 | ▼-1.344 | ▼-0.029 |
| Dividend Payout Ratio | 0.289 | ▼-0.035 | ▼-0.282 |
| Enterprise Value Multiple | 6.357 | ▼-2.129 | ▼-3.094 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $7.08B | $9.01B | $7.16B | $6.48B | $6.48B | |
| Enterprise value | $7.84B | $10.05B | $9.16B | $8.92B | $8.40B | |
| EV / Sales | 1.09x | 1.35x | 1.12x | 1.12x | 1.22x | |
| EV / Op. cash flow | 8.30x | 7.00x | 8.67x | 58.71x | 21.44x | |
| EV / Free cash flow | 15.34x | 8.85x | 12.37x | -60.30x | 91.34x | |
| EV / EBITDA | 6.36x | 8.49x | 7.82x | 9.09x | 15.51x | |
| Net debt / EBITDA | 0.62x | 0.88x | 1.71x | 2.49x | 3.54x | |
| Current ratio | 2.66x | 2.62x | 1.92x | 1.76x | 1.78x | |
| Income quality | 1.29x | 2.22x | 1.64x | 0.30x | 3.35x | |
| Graham number | $131 | $115 | $109 | $90 | $43 | |
| Graham net-net | -$17 | -$17 | -$29 | -$33 | -$30 | |
| Tax burden | 74.8% | 69.5% | 76.6% | 73.7% | 47.2% | |
| Interest burden | 96.3% | 96.0% | 88.0% | 87.1% | 77.0% | |
| Working capital | $2.19B | $2.07B | $1.63B | $1.43B | $1.19B | |
| Invested capital | $5.98B | $5.60B | $5.30B | $5.13B | $4.96B | |
| Return on assets | 9.2% | 8.7% | 8.4% | 6.5% | 1.7% | |
| Operating ROA | 13.5% | 11.7% | 12.6% | 10.5% | 4.5% | |
| Return on tangible assets | 11.0% | 10.5% | 10.1% | 7.9% | 2.1% | |
| Return on equity | 16.8% | 16.7% | 17.9% | 15.4% | 3.7% | |
| Return on invested capital | 11.8% | 9.9% | 11.6% | 9.1% | 2.7% | |
| Return on capital employed | 15.8% | 14.3% | 16.3% | 13.4% | 5.6% | |
| Earnings yield | 10.3% | 7.2% | 9.0% | 7.6% | 1.8% | |
| Free cash flow yield | 7.2% | 12.6% | 10.3% | -2.3% | 1.4% | |
| Capex / Op. cash flow | 45.9% | 21.0% | 29.9% | 197.4% | 76.5% | |
| Capex / Depreciation | 195.0% | 140.7% | 144.3% | 139.5% | 136.4% | |
| Capex / Sales | 6.0% | 4.1% | 3.9% | 3.8% | 4.4% | |
| SG&A / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.0% | 0.6% | 0.2% | 0.4% | 0.3% | |
| Intangibles / Total assets | 16.1% | 17.0% | 17.1% | 17.2% | 19.3% | |
| Days sales outstanding | 52d | 54d | 57d | 65d | 60d | |
| Days payables outstanding | 86d | 39d | 44d | 49d | 51d | |
| Operating cycle | 135d | 131d | 140d | 155d | 137d | |
| Cash conversion cycle | 49d | 91d | 95d | 106d | 86d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-08-05 Ingredion Q2 Earnings Beat Estimates on T&HS Volume Growth Ingredion beats Q2 estimates as 7% Texture & Healthful Solutions volume growth and FX gains offset Argo issues and higher costs.
- 2026-08-05 Amundi Boosts Stake in Ingredion Incorporated $INGR Amundi grew its holdings in shares of Ingredion Incorporated (NYSE: INGR) by 19.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 142,282 shares of the company''s stock after acquiring an additional 23,122 shares during the quarter. Amundi owned
- 2026-08-05 Ingredion Incorporated $INGR Shares Purchased by California State Teachers Retirement System California State Teachers Retirement System raised its position in Ingredion Incorporated (NYSE: INGR) by 27.0% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 76,804 shares of the company''s stock after purchasing an additional 16,333 shares during the quarter. California State Teachers
- 2026-08-05 Ingredion Q2 Earnings Call Highlights Ingredion (NYSE: INGR) reported second-quarter 2026 results that were in line with its expectations, as continued growth in Texture and Healthful Solutions offset operational and macroeconomic pressures in other parts of the portfolio. Second-quarter net sales increased 1% year over year to $1.85 billion. Reported operating income was $188 million, while adjusted operating income declined 5%
- 2026-08-05 Ingredion Q2 Earnings Call Highlights Ingredion NYSE: INGR reported second-quarter 2026 results that were in line with its expectations, as continued growth in Texture & Healthful Solutions offset operational and macroeconomic pressures in other parts of the portfolio.
- 2026-08-04 Ingredion Incorporated (INGR) Q2 2026 Earnings Call Transcript Ingredion Incorporated (INGR) Q2 2026 Earnings Call Transcript
- 2026-08-04 Ingredion (INGR) Q2 Earnings and Revenues Beat Estimates Ingredion (INGR) came out with quarterly earnings of $2.82 per share, beating the Zacks Consensus Estimate of $2.73 per share. This compares to earnings of $2.87 per share a year ago.
- 2026-08-04 Ingredion Incorporated Reports Second Quarter 2026 Results Second quarter 2026 reported and adjusted* operating income decreased 31% and 5% compared to the second quarter 2025 Second quarter 2026 reported and adjusted EPS were $1.78 and $2.82, compared with $2.99 and $2.87 in the second quarter 2025 Reaffirming amended full-year guidance, which now reflects the sale of a majority stake in the Pakistan business, for reported EPS to be in the range of $9.15 to $9.75 and adjusted EPS to be in the range of $10.30 to $10.90 Ingredion''s 595 pence all-cash offer to acquire Tate & Lyle accepted by their shareholders WESTCHESTER, Ill., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its second quarter 2026 results.
- 2026-08-03 Is Ingredion Stock a Buy as Cheap Valuation Meets Execution Risk? Ingredion''s cheap valuation and growing specialty business support the bull case, but Argo execution risks and weaker guidance argue for patience.
- 2026-08-03 How Ingredion''s Tate & Lyle Deal Could Reshape Its Growth Outlook Ingredion''s proposed $5 billion Tate & Lyle deal could expand its specialty platform and global reach, but approvals and integration risks remain.